BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23199325)

  • 1. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
    Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
    Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency.
    Borrelli M; Maglio M; Agnese M; Paparo F; Gentile S; Colicchio B; Tosco A; Auricchio R; Troncone R
    Clin Exp Immunol; 2010 May; 160(2):199-206. PubMed ID: 20030673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
    Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
    J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
    Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
    Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
    Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early developing celiac disease in children with cerebral palsy.
    Stenberg R; Kaukinen K; Bengtsson M; Lindberg E; Dahle C
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):674-8. PubMed ID: 21697743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease.
    Maglio M; Tosco A; Auricchio R; Paparo F; Colicchio B; Miele E; Rapacciuolo L; Troncone R
    Dig Liver Dis; 2011 Aug; 43(8):604-8. PubMed ID: 21342796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
    Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques.
    Dutta R; Iqbal A; Das P; Palanichamy JK; Singh A; Mehtab W; Chauhan A; Aggarwal A; Sreenivas V; Ahuja V; Datta Gupta S; Makharia GK
    J Clin Pathol; 2021 Dec; 74(12):766-773. PubMed ID: 33789921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.
    Maglio M; Florian F; Vecchiet M; Auricchio R; Paparo F; Spadaro R; Zanzi D; Rapacciuolo L; Franzese A; Sblattero D; Marzari R; Troncone R
    Diabetes; 2009 Jul; 58(7):1578-84. PubMed ID: 19401430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
    Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
    Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.